Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F. Mignotte H, et al. Among authors: lesur a. Int J Cancer. 1998 May 4;76(3):325-30. doi: 10.1002/(sici)1097-0215(19980504)76:3<325::aid-ijc7>3.0.co;2-x. Int J Cancer. 1998. PMID: 9579567
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)].
Fourquet A, Cutuli B, Luporsi E, Mauriac L, Garbay JR, Giard S, Spyratos F, Sigal-Zafrani B, Dilhuydy JM, Acharian V, Balu-Maestro C, Blanc-Vincent MP, Cohen-Solal C, De Lafontan B, Dilhuydy MH, Duquesne B, Gilles R, Lesur A, Shen N, Cany L, Dagousset I, Gaspard MH, Hoarau H, Hubert A, Monira MH, Perrié N, Romieu G. Fourquet A, et al. Among authors: lesur a. Cancer Radiother. 2002 Jun;6(4):238-58. doi: 10.1016/s1278-3218(02)00201-9. Cancer Radiother. 2002. PMID: 12224489 French.
[Standards, options and recommendations for the management of patients with infiltrating non metastatic breast cancer (2nd edition, 2001)--summary version].
Mauriac L, Luporsi E, Cutuli B, Fourquet A, Garbay JR, Giard S, Spyratos F, Sigal-Zafrani B, Dilhuydy JM, Acharian V, Balu-Maestro C, Blanc-Vincent MP, Cohen-Solal C, De Lafontan B, Dilhuydy MH, Duquesne B, Gilles R, Lesur A, Shen N; Fédération Nationale des Centres de Lutte Contre le Cancer; Standards, Options and Recommendations; Contre le Cancer: La Lique 101 Comités; Fédération Hospitalière de France; Fédération de Cancerologie des CHR & U. Mauriac L, et al. Among authors: lesur a. Gynecol Obstet Fertil. 2003 Mar;31(3):284-315. doi: 10.1016/s1297-9589(03)00048-1. Gynecol Obstet Fertil. 2003. PMID: 12846249 French. No abstract available.
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001).
Mauriac L, Luporsi E, Cutuli B, Fourquet A, Garbay JR, Giard S, Spyratos F, Sigal-Zafrani B, Dilhuydy JM, Acharian V, Balu-Maestro C, Blanc-Vincent MP, Cohen-Solal C, De Lafontan B, Dilhuydy MH, Duquesne B, Gilles R, Lesur A, Shen N, Cany L, Dagousset I, Gaspard MH, Hoarau H, Hubert A, Monira MH, Perrié N, Romieu G; FNCLCC. Mauriac L, et al. Among authors: lesur a. Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S17-31. doi: 10.1038/sj.bjc.6601081. Br J Cancer. 2003. PMID: 12915900 Free PMC article. No abstract available.
Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases.
Cutuli B, Kanoun S, Tunon De Lara C, Baron M, Livi L, Levy C, Cohen-Solal-Lenir C, Lesur A, Kerbrat P, Provencio M, Gonzague-Casabianca L, Mege A, Lemanski C, Delva C, Lancrenon S, Velten M. Cutuli B, et al. Among authors: lesur a. Crit Rev Oncol Hematol. 2012 Jan;81(1):29-37. doi: 10.1016/j.critrevonc.2011.01.005. Epub 2011 Feb 17. Crit Rev Oncol Hematol. 2012. PMID: 21333547
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.
Pujol P, Lasset C, Berthet P, Dugast C, Delaloge S, Fricker JP, Tennevet I, Chabbert-Buffet N, This P, Baudry K, Lemonnier J, Roca L, Mijonnet S, Gesta P, Chiesa J, Dreyfus H, Vennin P, Delnatte C, Bignon YJ, Lortholary A, Prieur F, Gladieff L, Lesur A, Clough KB, Nogues C, Martin AL; French Federation of Cancer Centres (FNCLCC). Pujol P, et al. Among authors: lesur a. Fam Cancer. 2012 Mar;11(1):77-84. doi: 10.1007/s10689-011-9484-4. Fam Cancer. 2012. PMID: 22076253 Clinical Trial.
81 results